A longitudinal study of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels.

Publisher: BioMed Central Country of Publication: England NLM ID: 101249759 Publication Model: Electronic Cited Medium: Internet ISSN: 1746-6148 (Electronic) Linking ISSN: 17466148 NLM ISO Abbreviation: BMC Vet Res Subsets: MEDLINE

Original Publication: London : BioMed Central, 2005-

Middle East Respiratory Syndrome Coronavirus*/genetics ; Coronavirus Infections*/epidemiology ; Coronavirus Infections*/veterinary; Animals ; Humans ; Camelus ; Longitudinal Studies ; Antibodies, Neutralizing

Background: Middle East respiratory syndrome coronavirus (MERS-CoV) was identified in humans in 2012. Since then, 2605 cases and 937 associated deaths have been reported globally. Camels are the natural host for MERS-CoV and camel to human transmission has been documented. The relationship between MERS-CoV shedding and presence of neutralizing antibodies in camels is critical to inform surveillance and control, including future deployment of camel vaccines. However, it remains poorly understood. The longitudinal study conducted in a closed camel herd in Egypt between December 2019 and March 2020 helped to characterize the kinetics of MERS-CoV neutralizing antibodies and its relation with viral shedding.
Results: During the 100-day longitudinal study, 27 out of 54 camels (50%) consistently tested negative for presence of antibodies against MERS-CoV, 19 (35.2%) tested positive and 8 (14.8%) had both, positive and negative test results. Fourteen events that could be interpreted as serological indication of probable infection (two seroconversions and twelve instances of positive camels more than doubling their optical density ratio (OD ratio) in consecutive samples) were identified. Observed times between the identified events provided strong evidence (p = 0.002) against the null hypothesis that they occurred with constant rate during the study, as opposed to clustering at certain points in time. A generalized additive model showed that optical density ratio (OD ratio) is positively associated with being an adult and varies across individual camels and days, peaking at around days 20 and 90 of the study. Despite serological indication of probable virus circulation and intense repeated sampling, none of the tested nasal swab samples were positive for MERS-CoV RNA, suggesting that, if the identified serological responses are the result of virus circulation, the virus may be present in nasal tissue of infected camels during a very narrow time window.
Conclusions: Longitudinal testing of a closed camel herd with past history of MERS-CoV infection is compatible with the virus continuing to circulate in the herd despite lack of contact with other camels. It is likely that episodes of MERS-CoV infection in camels can take place with minimal presence of the virus in their nasal tissues, which has important implications for future surveillance and control of MERS-CoV in camel herds and prevention of its zoonotic transmission.
(© 2023. The Author(s).)

Emerg Infect Dis. 2014 Jun;20(6):1049-53. (PMID: 24856660)
Heliyon. 2021 Oct 12;7(10):e08166. (PMID: 34703929)
Front Med. 2016 Jun;10(2):120-36. (PMID: 26791756)
Emerg Infect Dis. 2021 Jul;27(7):1964-1968. (PMID: 34152977)
Vector Borne Zoonotic Dis. 2017 Feb;17(2):155-159. (PMID: 28009529)
Lancet Infect Dis. 2004 Nov;4(11):704-8. (PMID: 15522683)
Emerg Infect Dis. 2017 Mar;23(3):550-551. (PMID: 28221127)
Epidemiol Infect. 2019 Jan;147:e84. (PMID: 30869000)
Comp Clin Path. 2022;31(3):537-546. (PMID: 35506144)
Emerg Infect Dis. 2021 Sep;27(9):2301-2311. (PMID: 34423762)
Emerg Microbes Infect. 2017 Jan 4;6(1):e1. (PMID: 28050021)
Euro Surveill. 2012 Dec 06;17(49):. (PMID: 23231891)
Euro Surveill. 2013 Dec 12;18(50):20659. (PMID: 24342517)
Emerg Infect Dis. 2014 Jun;20(6):1012-5. (PMID: 24857749)
Euro Surveill. 2013 Sep 05;18(36):pii=20574. (PMID: 24079378)
Emerg Microbes Infect. 2018 Nov 28;7(1):195. (PMID: 30482895)
Lancet Infect Dis. 2013 Oct;13(10):859-66. (PMID: 23933067)
Viruses. 2022 Aug 09;14(8):. (PMID: 36016365)
Emerg Infect Dis. 2019 Dec;25(12):2333-2335. (PMID: 31742534)
Viruses. 2019 Aug 05;11(8):. (PMID: 31387326)
Vet Q. 2020 Dec;40(1):190-197. (PMID: 32543343)
N Engl J Med. 2012 Nov 8;367(19):1814-20. (PMID: 23075143)
Int J Epidemiol. 2020 Jun 1;49(3):717-726. (PMID: 32086938)
Viruses. 2019 Mar 02;11(3):. (PMID: 30832356)
Sci Rep. 2019 Nov 8;9(1):16292. (PMID: 31705137)
Emerg Infect Dis. 2016 Dec;22(12):2171-2173. (PMID: 27224315)
N Engl J Med. 2014 Jun 26;370(26):2499-505. (PMID: 24896817)

Keywords: Coronavirus; Dromedary camel; Longitudinal study; MERS-CoV; Serology; Zoonosis

0 (Antibodies, Neutralizing)

Date Created: 20231103 Date Completed: 20231106 Latest Revision: 20231106

20231106

PMC10621169

10.1186/s12917-023-03769-z

37919680